Biopoly
Fort Wayne, US · Indiana LLC
BioPoly develops biomaterial implants made from a proprietary self-lubricating material combining hyaluronic acid and polyethylene for orthopedic applications, enabling partial joint resurfacing and cartilage replacement. The company serves orthopedic surgeons and patients seeking less invasive joint repair solutions, with products approved in Europe and the U.S.
Founders & leadership
HS
Herb Schwartz, PhDPresident & CEO, Founder
SS
Sheila Schwartz, RPhCOO, Founder
HS
Herb SchwartzPresident and CEO
SS
Sheila SchwartzChief Operating Officer
HE
Herbert E. SchwartzNamed on SEC filing
Board
SG
Scott GlazeBoard director
BC
Brian Curtis HodorekBoard director
RE
Robert E. Vitoux, Jr.Board director
RM
Roger MuselmanBoard director
TO
Todd O. DavisBoard director
KL
Karl LaPanBoard director
DK
Douglas KampenBoard director
Reported raises · per SEC filings
Form D private placements$3.1M disclosed across 3 of 4 rounds · 2016–2025
▶$1.1MraisedFeb 2025 · 1 investors · BiotechnologyRule 506(b)
▶$1.1MraisedFeb 2025 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Brian Curtis HodorekDirector
- Robert E. Vitoux, Jr.Director
- Roger MuselmanDirector
- Sheila SchwartzExecutive Officer, Director
- Herbert E. SchwartzExecutive Officer, Director
- Todd O. DavisDirector
- Offering amount
- $4M
- Amount sold
- $1.1M
- Minimum investment
- $100K
- First sale
- Jan 2025
- Incorporated
- Limited Liability Company, Indiana
- Federal exemptions
- 06b
▶$300KraisedJan 2023 · 4 investors · BiotechnologyRule 506(b)
▶$300KraisedJan 2023 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ryan SchlotterbackExecutive Officer
- Robert E. Vitoux, Jr.Director
- Herbert E SchwartzExecutive Officer, Director
- Sheila SchwartzExecutive Officer, Director
- Todd O DavisDirector
- Douglas KampenDirector
- Brian Curtis HodorekDirector
- Offering amount
- $7M
- Amount sold
- $300K
- Minimum investment
- $100K
- First sale
- Jan 2023
- Incorporated
- Limited Liability Company, Indiana
- Federal exemptions
- 06b
▶$2MofferedMay 2019 · BiotechnologyRule 506(b)
▶$2MofferedMay 2019 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- HERBERT E. SCHWARTZExecutive Officer, Director, Promoter
- SHEILA SCHWARTZDirector
- RICHARD TARRDirector
- TIMOTHY L. CLAXTONDirector
- KARL LAPANDirector
- SCOTT GLAZEDirector
- DOUGLAS KAMPENDirector
- Offering amount
- $2M
- Minimum investment
- $100K
- Proceeds to insiders
- $240K
- Incorporated
- Limited Liability Company, Indiana
- Federal exemptions
- 06b, 4a5
▶$1.7MraisedNov 2016 · 15 investors · BiotechnologyRule 506(b)
▶$1.7MraisedNov 2016 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Karl LaPanDirector
- Douglas KampenDirector
- Scott GlazeDirector
- Timothy ClaxtonDirector
- Richard TarrDirector
- Herbert E. SchwartzExecutive Officer, Director, Promoter
- Paul GilbertDirector
- Offering amount
- $5M
- Amount sold
- $1.7M
- Minimum investment
- $100K
- Proceeds to insiders
- $250K
- First sale
- Jan 2016
- Incorporated
- Limited Liability Company, Indiana
- Federal exemptions
- 06b, 4a5
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapRead the Press Release43 shared keywordsStryker is a medical technology company that develops and manufactures products across areas such as orthopaedics, surgical equipment, neurotechnology, and spine care for hospitals and healthcare providers. It operates globally across the Americas, Europe, Asia-Pacific, and the Middle East.
Doximity27 shared keywordsDoximity is the largest verified network of healthcare professionals in the U.S., connecting physicians, PAs, NPs, pharmacists, and medical students across specialties and care settings. The platform provides mobile-first tools for clinical communication, collaboration, and workflow optimization.
Vumedi18 shared keywordsVumedi operates a peer-to-peer video education platform where clinicians watch lectures and technique videos across dozens of medical specialties. It partners with academic institutions, hospitals, and life sciences companies to provide continuing medical education content to doctors.
Companies competing with Biopoly for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Biopoly do?
- BioPoly develops biomaterial implants made from a proprietary self-lubricating material combining hyaluronic acid and polyethylene for orthopedic applications, enabling partial joint resurfacing and cartilage replacement. The company serves orthopedic surgeons and patients seeking less invasive joint repair solutions, with products approved in Europe and the U.S.
- Who founded Biopoly?
- Biopoly was founded by Herb Schwartz, PhD, Sheila Schwartz, RPh.
- How much funding has Biopoly raised?
- Biopoly has disclosed $3.1M raised across 3 of its 4 known rounds.
- Where is Biopoly headquartered?
- Biopoly is headquartered in Fort Wayne, US.